Funder
German Academic Exchange Service
Dept. of Science and Technology
Publisher
Springer Science and Business Media LLC
Reference207 articles.
1. Ahmad, A. (2013). Pathways to breast cancer recurrence. ISRN Oncol, 2013, 290568,
https://doi.org/10.1155/2013/290568
.
2. Ahmad, A., Wang, Z., Ali, R., Bitar, B., Logna, F.T., Maitah, M.Y., Bao, B., Ali, S., Kong, D., Li, Y., & Sarkar, F.H. (2012). Cell cycle regulatory proteins in breast cancer: molecular determinants of drug resistance and targets for anticancer therapies. In R. Aft (Ed.), Targeting New Pathways and Cell Death in Breast Cancer, InTech (pp. 113–130).
https://doi.org/10.5772/24272
.
3. Ahmad, A., & Sarkar, F. (2013). Current understanding of drug resistance mechanisms and therapeutic targets in HER2 overexpressing breast cancers. In A. Ahmad (Ed.), Breast Cancer Metastasis and Drug Resistance (pp. 261-274): Springer New York.
4. Lehne, G., Elonen, E., Baekelandt, M., Skovsgaard, T., & Peterson, C. (1998). Challenging drug resistance in cancer therapy—review of the first Nordic conference on chemoresistance in cancer treatment, October 9th and 10th, 1997. Acta Oncologica, 37(5), 431–439.
5. Ringborg, U., & Platz, A. (1996). Chemotherapy resistance mechanisms. Acta Oncologica, 35(Suppl 5), 76–80.
Cited by
121 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献